Trending Topics
Sensex Live
PFC REC Merger
Gold Rate Today
India US Trade Deal
Fractal Analytics IPO

Buy Novartis India; target of Rs 744: Firstcall Research

Firstcall Research is bullish on Novartis India and has recommended buy rating on the stock with a target of Rs 744 in its March 24, 2011 research report.

March 25, 2011 / 14:29 IST
Story continues below Advertisement
Remove Ad

Firstcall Research is bullish on Novartis India and has recommended buy rating on the stock with a target of Rs 744 in its March 24, 2011 research report.

Read More

first published: Mar 25, 2011 02:23 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Follow Us On: Facebook twitter instagram linkedin youtube
Trending Topics
Sensex Today Piyush Goyal Delhi triple suicide India US Trade Deal PFC REC Merger Indian Rupee BSE Share Price Kanpur Lamborghini Accident India Pakistan T20 World Cup Valentine week 2026 full list
News
Business Markets Stocks India News City News Economy Mutual Funds Personal Finance IPO News Startups
Markets
Home Currencies Commodities Pre-Market IPO Global Market Bonds Silver MCX Price Gold MCX Price
Personal Finance
Home Loans up to 50 Lakhs Credit Cards Lifetime Free Finance Tracker New Fixed Deposits Fixed Deposit Comparison Fixed Income
Mutual Funds
Home MC 30 Top Ranked Funds ETFs Mutual Fund Screener
Tools
Income Tax Calculator EMI Calculator Retirement Planning Gratuity Calculator Petrol Price in India Diesel Price in India IFSC Code
Community
Stock Markets
Network 18 Sites
News18 Firstpost CNBC TV18 News18 Hindi Cricketnext Overdrive
Quick Links
About Us Contact Us Advisory Alert Advertise with Us Disclaimer Privacy Policy Cookie Policy Terms & Conditions Financial Terms (Glossary) Sitemap Investors
Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.